Mutares Stock - Czech Synthomer acquisition extends chemicals platform

Edited by ad hoc news Long-Term & Business-Model Desk. Verified prior to publication on 06/20/2026, 16:20 CET. Details in the imprint.

Mutares (DE000A0Z23Y2) is expanding its portfolio with the planned acquisition of Synthomer a.s., a Czech specialty chemicals business carved out from Synthomer plc. The transaction underpins the group’s long-term buy-and-build strategy in chemicals and adjacent industrials.

Czech Synthomer deal in focus

According to recent coverage, Mutares has signed an agreement to acquire Synthomer a.s., a producer of acrylate solutions based in Sokolov in the Czech Republic, from British group Synthomer plc, adding roughly 300 employees and about EUR 110 million in annual sales to its portfolio.

Reports state that the transaction has been structured as a carve-out without an upfront purchase price at closing, a deal pattern that fits Mutares' focus on complex corporate spin-offs and turnaround situations within its platform companies.

How the acquisition fits the long-term model

Mutares positions itself as a specialist for operational transformation of non-core units from larger industrial groups, building platforms in sectors such as automotive, engineering and chemicals with bolt-on acquisitions to drive scale and margin improvement over several years.

The planned integration of Synthomer a.s. is set to strengthen the chemicals platform by adding a specialty acrylates business with existing customer relationships, which management aims to optimize through operational measures and potential cross-selling with other portfolio companies.

The business behind the stock

Mutares generates value by acquiring underperforming or non-core businesses at low entry multiples, implementing restructuring and operational improvements, and ultimately targeting exits after a multi-year holding period, with proceeds intended to support dividends and new transactions.

Where the stock trades today

The shares of Mutares (DE000A0Z23Y2) trade on the Frankfurt Stock Exchange; the most recent verified quote and exact timestamp were not available at the time of editing, so no current price is stated here.

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.